390 related articles for article (PubMed ID: 7904434)
1. [Resistant schizophrenia: what chemotherapy?].
Vanelle JM
Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
[No Abstract] [Full Text] [Related]
2. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
[No Abstract] [Full Text] [Related]
3. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
4. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
5. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
6. Management of treatment-resistant patients with schizophrenia.
Marder SR
J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
[TBL] [Abstract][Full Text] [Related]
7. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
8. Simple schizophrenia in an adolescent.
Valentí M; Castro-Fornieles J; Lázaro ML; Sugrañes G; Baeza I
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):589-90. PubMed ID: 19877985
[No Abstract] [Full Text] [Related]
9. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
10. [Practical aspects of drug resistance in schizophrenia].
Jarema M; Kucińska M
Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
[TBL] [Abstract][Full Text] [Related]
11. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
[TBL] [Abstract][Full Text] [Related]
12. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological management of anxiety in patients suffering from schizophrenia].
Baylé FJ; Blanc O; De Chazeron I; Lesturgeon J; Lançon C; Caci H; Garay RP; Llorca PM
Encephale; 2011 May; 37 Suppl 1():S83-9. PubMed ID: 21600338
[TBL] [Abstract][Full Text] [Related]
14. [Quality of life of schizophrenic patients and clozapine].
Raoul Y; Manesse P; Delage M
Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
[TBL] [Abstract][Full Text] [Related]
15. The pharmacologic treatment of schizophrenia: a progress report.
Donaldson SR; Gelenberg AJ; Baldessarini RJ
Schizophr Bull; 1983; 9(4):504-27. PubMed ID: 6140750
[TBL] [Abstract][Full Text] [Related]
16. Concurrent psychotropic medication has no negative influence on the outcome of electroconvulsive therapy.
O'Brien PD; Berrios GE
Encephale; 1993; 19(4):347-9. PubMed ID: 7903929
[TBL] [Abstract][Full Text] [Related]
17. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
[No Abstract] [Full Text] [Related]
19. Benzodiazepines (BZ) for the management of psychosis.
Easton MS; Janicak PG
Psychiatr Med; 1991; 9(1):25-36. PubMed ID: 1673257
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and constipation: a serious issue.
Drew L; Herdson P
Aust N Z J Psychiatry; 1997 Feb; 31(1):149-50. PubMed ID: 9088503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
